Claire McCaskill

It is very difficult for investigations to be thorough and complete if you are thwarted from getting information.

Imagine my surprise when Peg Gustafson squared her shoulders and stood up to me and told me exactly why I was wrong on the law.

I had very strong opinions about it and that I was not shy about letting those opinions be known to everyone.

The oversight function performed by the Inspector General community will never be thorough and never be complete as long as there is information that is not available to the Inspector General community.

We just need more people to quit being hypocrites about balancing a budget, and be honest about what it takes to be fiscally responsible as it relates to our budget military.

I support the European Reassurance Initiative.

The only reason they're in two different budgets is an artificial cap put on by Congress to try to pretend to the American people that we're balancing something.

Well, you know, in some of the documents you gave us, you did not include the two cardiac drugs because you said, well, you increased it the day you received it.

Well, if there are errors in the report by Wells Fargo, you certainly have a chance to correct the record.

Well, it has been their business model from day one, and it is very hard for somebody with your sophistication on Wall Street and your track record on Wall Street--you understand it is a little hard for me to swallow that you were not…

I thank all of you for being here today, and we are glad, Mr. Pearson, you are feeling better.

Valeant has said that they have turned over a new leaf, that they have had a conversion on the road to Damascus.

I love free markets, but to call this a free market, Mr. Pearson, you are identifying drugs where there was not a free market, where there was a monopoly.

I want to thank you, though, Mrs. Heyman, for coming forward and talking about what you encountered.

My only comment on the call is you sounded a little defensive on the price increase question.

How can you guys say--how can you stand here now and apologize--which I think it is great.

Okay. Let us move on to the price increase on Isuprel and Nitropress.

Health care is the largest part of our Government debt and continues as far as the eye can see.

I think it is misleading to act as if this is a problem with four drugs. This is the business model.

I am glad to be here today for the third of our series of hearings about rising drug prices.

According to Wells Fargo securities report issued yesterday based on IMS and Price Rx data, the average price of your top 30 products is up 78 percent over last year.

Well, in the first quarter of 2016---you, Mr. Ackman, own at least 10 percent of this company.

I just wanted to make sure that clearly if you are--what did you say, second? Second largest shareholder in Valeant and you want to talk about drug pricing in Congress, lobbying.

To protect the American public, we must act to address these market failures.

I think, Mr. Pearson, honestly, to give the impression that these were isolated incredibly large price increases is just misleading.